Alector is kicking off a resource realignment effort that will include a workforce reduction of around 17%. The biotech ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

Dear Quentin,  I have two sisters who have developed Alzheimer’s disease. My younger sister is actually more severely ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the ...

Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...

Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the ...

In mice, inhibiting protein S-palmitoylation Counteracted accumulation of harmful proteins in neurons and delayed onset and progression of cognitive decline.

Imagine gradually losing the ability to express yourself—not because you've forgotten the words, but because they simply ...

Nov. 21—John Haldi had early-stage Alzheimer's disease when he began a local Aduhelm drug study in June 2020. For three years ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...